"Efficacy and safety evaluation of avatrombopag in immune thrombocytope" by Srikanth Nagalla

Menu

Skip to main content

All Publications

Srikanth Nagalla, Miami Cancer InstituteFollow

Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension

Publication Date

2-17-2022

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Platelets (2021) 33(2):257-264.

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS